Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Zydus Lifesciences Limited
Press Release May 09 2024
Business
May 9 2024
4 min read

Press Release May 09 2024

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 09, 2024, titled "Zydus Announces Completion of Enrolment for EPICS IIITM Phase 2b/3 trial evaluating Saroglitazar Mg in treatment of Primary Biliary Cholangitis".

View Attachment